Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL15061379 | 0.97 | TSHR (0.37) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Methoxymethane SCHEMBL28246973 | 0.91 | TSHR (0.33) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL17443155 | 0.89 | CA1 (0.36) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL27839069 | 0.87 | ALDH1A1 (0.42) | TSHRMAPK1ALDH1A1CA1CA2 | |
| SCHEMBL5168151 | 0.87 | CA1 (0.48) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL11459754 | 0.85 | — | — | |
| Ammonia Solution, Strong SCHEMBL8016891 | 0.84 | ALDH1A1 (0.40) | TSHRALDH1A1CA1CA2 | |
| SCHEMBL28278123 | 0.84 | CA1 (0.46) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL27608962 | 0.84 | CA1 (0.46) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL11694067 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113846365-A | Forming method of bionic porous structure with hydrophobic resistance reduction capability | 中国船舶重工集团公司第七二五研究所 | 2021-12-28 | — | — | CN | claimed |
| CN-116162079-B | Synthesis method of aminocoumarin compound | 浙江工业大学 | 2024-09-17 | — | — | CN | disclosed |
| CN-118010867-A | Analysis and detection method for content of 2-hydroxy glycol hydrogen sulfate | 青岛科技大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-114608716-B | Flexible temperature and pressure bimodal sensor and preparation and testing method thereof | 广东粤港澳大湾区协同创新研究院 | 2023-08-25 | — | — | CN | disclosed |
| CN-116162079-A | Synthesis method of aminocoumarin compound | 浙江工业大学 | 2023-05-26 | — | — | CN | disclosed |
| US-11427523-B2 | Bisphenol composition containing aromatic alcohol sulfonate and method for producing same, polycarbonate resin and method for producing same, and bisphenol production method | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-08-30 | — | — | US | disclosed |
| CN-114829560-A | Macrocyclic ring with powdery and musk smelling agents | 弗门尼舍有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114761526-A | Green scent agent | 弗门尼舍有限公司 | 2022-07-15 | — | — | CN | disclosed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| CN-113846365-A | Forming method of bionic porous structure with hydrophobic resistance reduction capability | 中国船舶重工集团公司第七二五研究所 | 2021-12-28 | — | — | CN | disclosed |
| EP-1215228-A2 | Optical coating film | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2002-06-19 | — | — | EP | disclosed |
| CN-1346849-A | Composition contg. organic oil-in-water emulsion, salt, alcohol and solvent | DOW CORNING INC (US) | 2002-05-01 | — | — | CN | disclosed |
| US-20020022610-A1 | Compositions and methods for treating bacterial infections | PHARMACIA & UPJOHN COMPANY | 2002-02-21 | — | — | US | disclosed |
| WO-2002002095-A2 | COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS CONTAINING OXAZOLIDINONE COMPOUND, SULBACTAM AND AN AMPICILLIN | PHARMACIA & UPJOHN COMPANY (US) | 2002-01-10 | — | — | WO | disclosed |
| US-6277982-B1 | REACTING CARBOHYDRATE, OLIGONUCLEOTIDE, NUCLEOTIDE OR NUCLEOSIDE WITH CYCLIC SULFATE; PRODUCTION OF OLIGONUCLEOTIDES WITH IMPROVED HYBRIDIZATION AFFINITY AND NUCLEASE RESISTANCE | ISIS PHARMACEUTICALS, INC. | 2001-08-21 | — | — | US | disclosed |
| US-4924007-A | Process for the preparation of cyclic sulphates | RHONE-POULENC SANTE (FR) | 1990-05-08 | — | — | US | disclosed |
| EP-0120550-B1 | FOAMING AGENT | GAF CORPORATION (US) | 1989-04-19 | — | — | EP | disclosed |
| US-4524002-A | ALKYL ETHER SULFONATGES AS FOAMING AGENTS | GAF CORPORATION (US) | 1985-06-18 | — | — | US | disclosed |
| EP-0120550-A2 | Foaming agent | GAF CORPORATION (US) | 1984-10-03 | — | — | EP | disclosed |
| US-4317938-A | SULFATION OF AN OLEFIN, REACTION WITH AN ALKYLENE OR POLYALKYLENE GLYCOL | SHELL OIL COMPANY (US) | 1982-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | TSHR 1973/4885MAPK1 1476/4885MEN1 1056/4885 |
| US-20020022610-A1 | Compositions and methods for treating bacterial infections | BPGM, MGAM, OXA1L | TSHR 4857/4885MAPK1 4601/4885MEN1 4105/4885 |
| US-11427523-B2 | Bisphenol composition containing aromatic alcohol sulfonate and method for producing same, polycarbonate resin and method for producing same, and bisphenol production method | ASH2L, FHIT, ADH1C | TSHR 3376/4885MAPK1 2025/4885MEN1 4577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.